R. Guilard et al.
AHCTUNGTERG[NNUN 2,12-(Diethoxyphosphoryl)-5,10,15,20-tetraphenyl-porphyrinato]zinc
Experimental Section
(5Zn) and [2,13-(diethoxyphosphoryl)-5,10,15,20-tetraphenyl-porphyrina-
to]zinc (6Zn): A 15 mL round bottom flask equipped with a reflux con-
denser and a magnetic stir bar was charged with the bromoporphyrin
All chemicals used were of analytical grade and were purchased from
Acros and Aldrich Co. unless stated otherwise. Silica gel (0.04–0.063 mm,
230–400 mesh ASTM, Merck) was used for column chromatography. An-
alytical thin-layer chromatography (TLC) was carried out by using
Merck silica gel 60 plates (precoated sheets, 0.2 mm thick, with fluores-
cence indicator F254). [5,10,15,20-Tetraphenyl]porphyrin (H2TPP),[73] [2-
bromo-5,10,15,20-tetraphenyl]porphyrin (H2TPPBr), and[60,64] [2,3,12,13-
tetrabromo-5,10,15,20-tetraphenyl]porphyrin (H2TPPBr4),[62] were pre-
pared and metallated[63] to afford [2-bromo-5,10,15,20-tetraphenylpor-
phyrinato]zinc (ZnTPPBr) and [2,3,12,13-tetrabromo-5,10,15,20-tetra-
phenyl-porphyrinato]zinc (ZnTPPBr4) according to literature procedures.
H2TPPBr4 (100 mg, 0.108 mmol), PdACHTUNGRTENUNG(OAc)2 (24.1 mg, 0.108 mmol), and
PPh3 (86.8 mg, 0.323 mmol). The flask was then evacuated and purged
with N2 three times. Toluene (abs., 9 mL), EtOH (abs., 6 mL), diethyl-
phosphite (165 mL, 1.290 mmol), and triethylamine (225 mL, 1.613 mmol)
were added through a syringe and the resulting mixture was heated to
reflux for 5 days until complete conversion of the bromide. The mixture
was then cooled and concentrated to give a solid, which was purified by
column chromatography on silica gel by using CHCl3 and hexane, fol-
lowed by CHCl3 and MeOH as eluent. The brown fraction (MeOH/
CHCl3, 1:99 (v/v)) was collected and evaporated to give a mixture (1:1)
of 2,12- and 2,13-diethoxyphosphoryl-5,10,15,20-tetraphenylporphyrins
(5H2 and 6H2) (77.1 mg, 81%). The attempts to separate these porphyr-
ins by using column chromatography were unsuccessful. The individual
compounds were obtained as zinc complexes after metallation of the por-
[2-(Diethoxyphosphoryl)-5,10,15,20-tetraphenyporphyrin (1H2): A 15 mL
round bottom flask equipped with a reflux condenser and a magnetic stir
bar was charged with the bromoporphyrin H2TPPBr (25 mg,
0.036 mmol), PdACHTUNGTRENNUNG(OAc)2 (8.1 mg, 0.036 mmol), and PPh3 (28.3 mg,
0.108 mmol). The flask was then evacuated and purged with N2 three
times. Toluene (abs., 3 mL), diethylphosphite (55 mL, 0.432 mmol), and
triethylamine (75 mL, 0.540 mmol) were added through a syringe and the
resulting mixture was heated to reflux for 4 h until complete conversion
of the bromide. Upon cooling the mixture was concentrated to give a
solid, which was purified by column chromatography on silica gel by
using CHCl3 and hexane as eluent. The reddish-purple fraction (CHCl3/
hexane, 80:20 (v/v)) was collected and concentrated to give 1H2 as a
phyrins mixture with ZnACHTNUGTRNEG(UN OAc)2·2H2O by using the procedure described
for ZnTPPBr. Purification by column chromatography on silica gel
(MeOH/CHCl3, 1:99 (v/v)) allowed to isolate 5Zn and 6Zn.
AHCTUNGTERG[NNUN 2,12-(Diethoxyphosphoryl)-5,10,15,20-tetraphenyl-porphyrinato]zinc
(5Zn): 1H NMR (600 MHz, CDCl3/CD3OD, 1:1 (v/v)): d=9.15 (d, J=
8.2 Hz, 2H; b-H), 8.39 (d, J=4.7 Hz, 2H; b-H), 8.15 (d, J=4.7 Hz, 2H;
b-H), 7.84 (m, 4H; o-Ph), 7.81 (m, 4H; o-Ph), 7.42 (m, 8H; m-Ph), 7.30
(t, J=7.7 Hz, 4H; p-Ph), 3.67 (m, 8H; CH2), 0.96 ppm (t, J=7.1 Hz,
12H; CH3); 31P NMR (600 MHz, CDCl3/CD3OD, 1:1 (v/v)): d=
17.5 ppm; MS (MALDI TOF): m/z calcd for (C52H46N4O6P2Zn)+: 950.3;
found: 950 [M]+; IR (powder, micro-ATR): n˜ =1232 cmÀ1 (P=O); UV/
Vis (CHCl3): (loge) lmax =431 (5.03), 504 (sh), 525 (sh), 566 (3.62),
612 nm (3.58).
1
purple solid in 87% (23.5 mg) yield. H NMR (600 MHz, CDCl3/CD3OD,
1:1 (v/v)): d=9.05 (d, J=8.3 Hz, 1H; b-H), 8.51 (d, J=4.4 Hz, 1H; b-H),
8.47 (d, J=4.4 Hz, 1H; b-H), 8.39 (d, J=4.4 Hz, 1H; b-H), 8.26 (m, 3H;
b-H), 7.79 (m, 4H; o-Ph), 7.69 (m, 4H; o-Ph), 7.32 (m, 12H; m-Ph, p-
Ph), 3.60 (m, 4H; CH2), 0.88 (t, J=7.2 Hz, 6H; CH3), À3.00 ppm (s, 2H;
NH); 31P NMR (300 MHz, CDCl3/CD3OD, 1:1 (v/v)): d=16.5 ppm; MS
(MALDI TOF): m/z calcd for (C48H39N4O3P)+: 750.3; found: 751
[M+H]+; IR (powder, micro-ATR): n˜ =1245 cmÀ1 (P=O); UV/Vis
(CHCl3): (loge) lmax =424 (5.34), 489 (sh), 522 (4.02), 559 (3.56), 599
(3.53), 656 nm (3.65).
AHCTUNGTERG[NNUN 2,13-(Diethoxyphosphoryl)-5,10,15,20-tetraphenyl-porphyrinato]zinc
(6Zn): 1H NMR (600 MHz, CDCl3/CD3OD, 1:1 (v/v)): d=9.10 (d, J=
8.2 Hz, 2H; b-H), 8.46 (s, 2H; b-H), 7.96 (s, 2H; b-H), 7.82 (dd, J=7.7,
1.6 Hz, 4H; o-Ph), 7.74 (d, J=7.7 Hz, 4H; o-Ph), 7.33 (m, 12H; m-Ph, p-
Ph), 3.62 (m, 8H; CH2), 0.92 ppm (t, J=7.1 Hz, 12H; CH3); 31P NMR
(600 MHz, CDCl3/CD3OD, 1:1 (v/v)): d=17.5 ppm; MS (MALDI TOF):
m/z calcd for (C52H46N4O6P2Zn)+: 950.3; found: 950 [M]+; IR (powder,
micro-ATR): n˜ =1240 cmÀ1 (P=O); UV/Vis (CHCl3): (loge) lmax =433
(4.85), 500 (sh), 529 (sh), 566 (3.44), 612 nm (3.36).
[2-(Diethoxyphosphoryl)-5,10,15,20-tetraphenyl-porphyrinato]zinc (1Zn):
The same procedure as for ZnTPPBr was applied and yielded the prod-
1
uct in 78% (19,6 mg). H NMR (600 MHz, CDCl3/CD3OD, 1:1 (v/v)): d=
9.16 (d, J=8.2 Hz, 1H; b-H), 8.48 (m, 2H; b-H), 8.45 (m, 2H; b-H), 8.36
(d, J=4.5 Hz, 1H; b-H), 8.13 (d, J=4.5 Hz, 1H; b-H), 7.83 (m, 8H; o-
Ph), 7.40 (m, 12H; m-Ph, p-Ph), 3.66 (m, 4H; CH2), 0.95 ppm (t, J=
7.1 Hz, 6H; CH3); 31P NMR (600 MHz, CDCl3/CD3OD, 1:1 (v/v)): d=
18.2 ppm; MS (MALDI TOF): m/z calcd for (C48H39N4O3P)+: 752;
found: 750.8 [MÀZn+H]+; MS (MALDI TOF): m/z calcd for
(C48H37N4O3PZn)+; 812.2; found: 813 [M+H]+; IR (powder, micro-
ATR): n˜ =1228 cmÀ1 (P=O); UV/Vis (CHCl3): (log e) lmax =429 (5.49),
524 (sh), 562 (4.08), 604 nm (3.77).
[2-(Diisopropoxyphosphoryl)-5,10,15,20-tetraphenyl-porphyrinato]zinc
(3Zn): A 15 mL round bottom flask equipped with a reflux condenser
and a magnetic stir bar was charged with the (bromoporphyrinato)zinc
ZnTPPBr (20 mg, 0.026 mmol), CuI (15 mg, 0.079 mmol), and Cs2CO3
(121 mg, 0.370 mmol). The flask was then evacuated and purged with N2
three times. Toluene (abs., 3 mL), diisopropylphosphite (106 mL,
0.634 mmol), and dimethylethylenediamine (60 mL, 0.555 mmol) were
added through a syringe and the resulting mixture was heated to reflux
for 2 days until complete conversion of the bromide. The mixture was
then cooled and concentrated to give a solid, which was purified by
column chromatography on silica gel by using CH2Cl2 and methanol as
eluent. The purple fraction (CH2Cl2/methanol, 99:1 (v/v)) was collected
and evaporated to give 3Zn as a purple solid in 86% (18.9 mg) yield.
1H NMR (300 MHz, CDCl3/CD3OD, 3:2 (v/v)): d=9.24 (d, J=8.4 Hz,
1H; b-H), 8.59 (m, 2H; b-H), 8.55 (m, 2H; b-H), 8.45 (d, J=4.8 Hz, 1H;
b-H), 8.20 (d, J=4.8 Hz, 1H; b-H), 7.92 (m, 8H; o-Ph), 7.43 (m, 12H; m-
Ph, p-Ph), 4.36 (m, 2H; CH), 1.02 (m, 6H; J=6.2 Hz, CH3), 0.98 ppm
(m, 6H; J=6.2 Hz, CH3); 31P NMR (300 MHz, CDCl3/CD3OD, 3:2 (v/v)):
d=14.9 ppm; HRMS (ESI, positive mode): m/z calcd for
(C50H41N4NaO3PZn)+: 863.21000; found: 863.20792 [M+Na]+; IR
(powder, micro-ATR): n˜ =1230 (sh), 1213 cmÀ1 (P=O); UV/Vis (CHCl3):
(loge) lmax =431 (5.56), 565 (4.18), 607 nm (3.93).
[2-(Dibutoxyphosphoryl)-5,10,15,20-tetraphenyl-porphyrinato]zinc
(2Zn): A 15 mL round bottom flask equipped with a reflux condenser
and a magnetic stir bar was charged with the (bromoporphyrinato)zinc
ZnTPPBr (20 mg, 0.026 mmol), CuI (15.1 mg, 0.079 mmol), and Cs2CO3
(120.5 mg, 0.370 mmol). The flask was then evacuated and purged with
N2 three times. Toluene (abs., 3 mL), dibutylphosphite (124 mL,
0.634 mmol), and dimethylethylenediamine (60 mL, 0.555 mmol) were
added through a syringe and the resulting mixture was heated to reflux
for 12 h until complete conversion of the bromide. The mixture was then
cooled and concentrated to give a solid, which was purified by column
chromatography on silica gel by using CHCl3 and hexane as eluent. The
purple fraction (CHCl3/hexane, 60:40 (v/v)) was collected and evaporated
to give 2Zn as
a
purple solid in 94% (21.4 mg) yield. 1H NMR
(300 MHz, CDCl3/CD3OD, 1:1 (v/v)): d=9.16 (d, J=8.1 Hz, 1H; b-H),
8.48 (m, 4H; b-H), 8.36 (d, J=4.8 Hz, 1H; b-H), 8.13 (d, J=4.8 Hz, 1H;
b-H), 7.84 (m, 8H; o-Ph), 7.35 (m, 12H; m-Ph, p-Ph), 3.60 (m, 4H;
CH2), 1.30 (m, 4H; CH2), 1.03 (m, 4H; CH2), 0.58 ppm (t, J=7.4 Hz,
6H; CH3); 31P NMR (300 MHz, CDCl3/CD3OD, 1:1 (v/v)): d=18.1 ppm;
MS (MALDI TOF): m/z calcd for (C52H45N4O3PZn)+: 868.3; found: 870
[M+2H]+; IR (powder, micro-ATR): n˜ =1220 cmÀ1 (P=O); UV/Vis
(CHCl3):] (loge) lmax =430 (5.60), 527 (sh), 562 (4.18), 605 nm (3.85).
[2-(Dibutoxyphosphoryl)-5,10,15,20-tetraphenyl]porphyrin
(2H2):
A
15 mL round bottom flask equipped with a reflux condenser and a mag-
netic stir bar was charged with the bromoporphyrin H2TPPBr (18.5 mg,
0.026 mmol), PdACHTNUTRGNE(UNG OAc)2 (6 mg, 0.026 mmol), and PPh3 (21 mg,
0.08 mmol). The flask was then evacuated and purged with N2 three
times. Toluene (abs., 3 mL), dibutylphosphite (62 mL, 0.32 mmol), and
15102
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2012, 18, 15092 – 15104